30. Dungan K, DeSantis A. Glucagon-like peptide 1-based therapies for the treatment of type 2 diabetes mellitus. UpToDate. November 9, 2023. Accessed November 29, 2023. www. uptodate . com / contents / glucagon - like - peptide - 1 - based - therapies - for - the - treatment - of - type - 2 - diabetes - mellitus
31. Trujillo JM, Nuffer W, Smith BA. GLP-1 receptor agonists: an updated review of head-to-head clinical studies. Ther Adv Endocrinol Metab. 2021;12:204201882199732. doi:10 . 1177 / 2042018821997320
32. Wharton S, Davies M, Dicker D, et al. Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgrad Med. 2021;134(1):14-19. doi:10 . 1080 / 00325481 . 2021 . 2002616
33. Meneghini L. Medical Management of Type 2 Diabetes. 8th ed. American Diabetes Association; 2020.
34. Ruedy KJ, Parkin CG, Riddlesworth TD, Graham C. Continuous glucose monitoring in older adults with type 1 and type 2 diabetes using multiple daily injections of insulin: results from the DIAMOND trial. J Diabetes Sci Technol. 2017;11(6):1138-1146. doi:10 . 1177 / 1932296817704445